These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Medicare coverage of hospice care.
    Author: Podell LB.
    Journal: Am J Hosp Pharm; 1984 May; 41(5):942-4. PubMed ID: 6375358.
    Abstract:
    Recently enacted regulations regarding Medicare coverage of hospice care are discussed. The hospice benefit, whether provided in a home or inpatient setting, is available to individuals entitled to Medicare Part A benefits and who are certified as being terminally ill. Hospice care coverage is authorized for a maximum of six months plus 30 days. Conditions of participation of the final regulations require that critical services (nursing services, physician services, and drugs and biologicals) be available on a 24-hour basis. Also, freestanding hospices must employ or contract a licensed pharmacist for control and accountability of all drugs throughout the facility. Reimbursement rates are mandated as all-inclusive, per diem rates that favor home care and have a per capita limit of $6500. The hospice benefit is a distinctly new choice of care for terminally ill patients. It also provides pharmacists an opportunity to participate in a unique aspect of health care.
    [Abstract] [Full Text] [Related] [New Search]